Enhance your practice with CME and tools that focus on the management of neurological conditions.
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Kaitlin Batley, MD
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Navigating Emerging Biomarkers in MS Care
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
David Weisman, MD
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Recognizing the Signs of TK2 Deficiency
Uncovering TK2d: How to Navigate Diagnostic Challenges
Exploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
The Role of B-Cell Depletion in MS Care
Precision Medicine for Myasthenia Gravis
Outcome Measures Capture Progression in Late-Onset TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.